Xeris Biopharma Holdings, Inc. Common Stock (XERS) is a publicly traded Healthcare sector company. As of May 21, 2026, XERS trades at $6.23 with a market cap of $1.04B and a P/E ratio of 88.21. XERS moved +5.07% today. Year to date, XERS is -12.13%; over the trailing twelve months it is +22.64%. Its 52-week range spans $2.69 to $10.08. Analyst consensus is strong buy with an average price target of $12.25. Rallies surfaces XERS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Xeris Biopharma Holdings, Inc. Common Stock (XERS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XERS moved +5.07% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.23 |
| Market Cap | $1.04B |
| P/E Ratio | 88.21 |
| EPS | $0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.08 |
| 52-Week Low | $2.69 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $314.85M |
| Net Income | $12.01M |
| Gross Margin | 0.00% |
4 analysts cover XERS: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.25.